Emergency Room Online Check-in

Welcome to Providence Children's Hospital

A Legacy of Care

A Message from the Market Chief Executive Officer:

CEO Nicholas Tejeda and patientAs CEO of The Hospitals of Providence Children’s Hospital, I have the unique privilege to lead a group of dedicated women and men committed to care for, support and protect our most vibrant yet vulnerable members of society. As a team, we are inspired each day by the courage our young patients exhibit during their stay at our hospital. Their smiles and courageous attitudes keep us striving to be our very best.

Founded in 1996, the hospital was the first of its kind in El Paso, focused on providing specialized care for children. The hospital is located on The Hospitals of Providence Memorial Campus and is part of the network that includes some of the region’s most trusted hospitals.

As the region’s leading children’s hospital, our team is trained and specialized to treat our smallest patients in a family-centered environment with resources designed just for children.

Committed to growing and expanding specialty care needed for the children of El Paso, in 2017, we opened the first Pediatric Emergency Room committed to offering care for your child’s emergency situation with healthcare professionals trained to treat the needs of pediatric patients. We also unveiled Providence Children’s Specialty Clinic providing El Paso children with specialists trained to treat behavioral, nutritional, and rehabilitation concerns. In addition, Providence Children’s Imaging Center opened its doors offering imaging needs to pediatric patients in a child-friendly environment.

The Hospitals of Providence Children’s Hospital is committed to providing the very best care to your most important treasure. Please know your child’s comfort and care is our top priority.

Thank you for trusting in Providence Children’s Hospital.

With gratitude, we invite you to further explore the services available at Providence Children’s Hospital.


Nicholas Tejeda
Group Chief Executive Officer, The Hospitals of Providence

News & Announcements

The Hospitals of Providence Administering COVID-19 Infusion Treatment in Individuals 12 Years and Older to Reduce Need for Hospital Stays

Aug 12, 2021

EL PASO, TX – In its continued effort to lead the community through the COVID-19 pandemic, The Hospitals of Providence continues to administer the COVID-19 monoclonal antibody infusion treatment in individuals 12 years of age and older to reduce the risk of patients needing to be hospitalized or becoming severely ill with COVID-19. The monoclonal antibody infusion treatment is now available as a preventative measure for individuals who are at risk of becoming severely ill from COVID-19 or have not been fully vaccinated and have been exposed to a COVID-19 positive individual.

The Hospitals of Providence is the only El Paso provider to offer the monoclonal antibody infusion treatment. All infusion treatments are administered at the Memorial Campus.

“The health and well-being of our community remains our highest priority and as we begin to see an increase in COVID-19 cases we are focused on ensuring these types of therapies are readily available to help protect our family, friends and loved ones from becoming severely ill,” said Nicholas Tejeda, Group CEO for The Hospitals of Providence. “This infusion treatment has proven itself to be an effective tool to reduce the severity of symptoms in COVID-19 patients, as well as a preventative treatment for patients who have been exposed to someone with COVID-19 and they themselves are at a high-risk of becoming severely ill with COVID-19 – our goal is to reduce the need for patients to be hospitalized.”

Monoclonal antibody infusion treatment is intended for patients who meet the following criteria:

  • Have been exposed or been in close contact to an individual who is COVID-19 positive and you are at high risk for progression of severe COVID-19
  • Tested positive for COVID-19
  • Non-hospitalized adults and adolescents 12 years of age and older
  • Mild to moderate symptoms
  • Within 10 days of symptom onset

Patients who have received a positive test result for COVID-19 OR patients who have come in close contact with an individual who is COVID-19 positive and are at risk of developing severe illness, should talk with their doctor or healthcare provider to see if monoclonal antibody infusion treatment is right for them.